EMIL (Epigenetic Marker Ipomethylated for acute promyelocytic Leukemia) nasce dalla valorizzazione economica e scientifica del brevetto EP3458607 che ha come oggetto l’uso di una signature epigenetica in ambito prognostico e/o diagnostico per la valutazione precoce della Leucemia Promielocitica Acuta (LPA). … Read More
Hypoxia-Regulated miRNAs in Human Mesenchymal Stem Cells: Exploring the Regulatory Effects in Ischemic Disorders
di Carmela Dell’Aversana — Permanent full researcher, at IEOS – CNR – ITALY — Human mesenchymal/stromal stem cells (hMSC) are the most promising cell source for adult cell therapies in regenerative medicine. Many clinical trials have reported the use of … Read More